GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (XSWX:SHL) » Definitions » Debt-to-EBITDA

Siemens Healthineers AG (XSWX:SHL) Debt-to-EBITDA : 0.18 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Siemens Healthineers AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF201 Mil. Siemens Healthineers AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF431 Mil. Siemens Healthineers AG's annualized EBITDA for the quarter that ended in Dec. 2023 was CHF3,550 Mil. Siemens Healthineers AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.18.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Siemens Healthineers AG's Debt-to-EBITDA or its related term are showing as below:

XSWX:SHL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01   Med: 0.05   Max: 0.19
Current: 0.17

During the past 9 years, the highest Debt-to-EBITDA Ratio of Siemens Healthineers AG was 0.19. The lowest was 0.01. And the median was 0.05.

XSWX:SHL's Debt-to-EBITDA is ranked better than
81.92% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 1.25 vs XSWX:SHL: 0.17

Siemens Healthineers AG Debt-to-EBITDA Historical Data

The historical data trend for Siemens Healthineers AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG Debt-to-EBITDA Chart

Siemens Healthineers AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only 0.05 0.17 0.19 0.16 0.17

Siemens Healthineers AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.20 0.17 0.13 0.18

Competitive Comparison of Siemens Healthineers AG's Debt-to-EBITDA

For the Medical Devices subindustry, Siemens Healthineers AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's Debt-to-EBITDA falls into.



Siemens Healthineers AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Siemens Healthineers AG's Debt-to-EBITDA for the fiscal year that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(189.137 + 418.597) / 3630.083
=0.17

Siemens Healthineers AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(200.875 + 430.985) / 3549.736
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Siemens Healthineers AG  (XSWX:SHL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Siemens Healthineers AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Siemens Healthineers AG (XSWX:SHL) Business Description

Address
Siemensstr. 3, Forchheim, BY, DEU, 91301
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.

Siemens Healthineers AG (XSWX:SHL) Headlines

No Headlines